A Pharmacy-Driven Fax Program Increases the Use of ACE Inhibitors and Angiotensin Receptor Blockers in Diabetes Patients


External link:* https://www.medcoresearch.com/docs/DOC-1221

The American Diabetes Association recommends the use of ace inhibitors (ACE-I) or angiotensin receptor blockers (ARB) in diabetes patients with certain clinical conditions, such as nephropathy or hypertension. However, these agents are not frequently prescribed to many patients for whom treatment is indicated.

Author: Rob Konkus, RPh, Jennifer Utterdyke, RPh, et al.

Related numbers to fix: $116 Billion, 23,600,000

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

If approved, your first name and first initial of your last name will be published to the site with your comment.


Submit
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
3 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

* = required field

divider
* By selecting an external link, you will be leaving the Making Medicine Smarter website and linking to another website which may be governed by a separate and different Terms of Use and Privacy Policy.

Medco is a registered trademark and Medco Making Medicine Smarter is a trademark of Medco Health Solutions, Inc.
Copyright 2009 Medco Health Solutions, Inc. All Rights Reserved.